Prehospital Blood Test Can Rapidly Differentiate Stroke Types
By Elana Gotkine HealthDay Reporter
.jpg?width=1200)
FRIDAY, Jan. 31, 2025 -- Prehospital measurement of glial fibrillary acidic protein (GFAP) can rapidly differentiate intracerebral hemorrhage (ICH) from ischemic stroke (IS) and stroke mimics, according to a study presented at the annual American Stroke Association International Stroke Conference, held from Feb. 5 to 7 in Los Angeles.
Love-Preet Kalra, M.D., from RKH Hospital Klinikum Ludwigsburg in Germany, and colleagues examined the potential of a new GFAP point-of-care test for rapidly distinguishing ICH from IS and stroke mimics in the prehospital phase in a study enrolling 353 patients with acute stroke admitted within six hours of symptom onset. Blood samples were collected in the prehospital phase, and plasma GFAP measurements were performed (duration of analysis, 15 minutes). The final diagnosis at hospital discharge, categorized as ICH, IS, or stroke mimics, was used as the gold standard.
The researchers found that GFAP concentrations were strongly elevated in patients with ICH compared with patients with IS and stroke mimics (median, 208 pg/mL versus 30 and 48 pg/mL, respectively). Compared with non-anticoagulated patients, patients with anticoagulation-associated ICH had higher GFAP values. Cutoff points were ascertained, which facilitated ICH diagnosis across age groups with high positive predictive values (90.0 to 95.5 percent). In contrast, GFAP values below 30 pg/mL ruled out ICH with a negative predictive value of 100 percent in patients with a moderate-to-severe neurological deficit.
"It is crucial to differentiate these two types of stroke because they need opposite treatments," Kalra said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
FRIDAY, June 6, 2025 -- For patients who undergo percutaneous coronary intervention (PCI) and discontinue dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.